RVL PHARMACEUTICALS PLC (RVLP) Stock Analyst Earnings Estimates
NASDAQ:RVLP - Nasdaq - IE00BF2HDL56 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 177.884M -25.89% | 17.501M -90.16% | 49.721M 184.10% | 38.023M -23.53% | 54.887M 44.35% | 77.164M 40.59% | 174.93M 126.70% | 231.03M 32.07% | 288.46M 24.86% | 347.41M 20.44% | 407.8M 17.38% | |
| EBITDA YoY % growth | 22.773M -62.09% | -72.335M -417.63% | -42.405M 41.38% | -17.34M 59.11% | 5.1M 129.41% | 18.36M 260.00% | 26.932M 46.69% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 1.747M -42.76% | -80.51M -4,708.47% | -42.78M 46.86% | -46.656M -9.06% | -23.856M 48.87% | -8.948M 62.49% | 65.994M 837.53% | 108.12M 63.83% | 151.47M 40.09% | 195.94M 29.36% | 241.64M 23.32% | |
| Operating Margin | 0.98% | -460.03% | -86.04% | -122.71% | -43.46% | -11.60% | 37.73% | 46.80% | 52.51% | 56.40% | 59.25% | |
| EPS YoY % growth | -1.29 52.75% | -1.01 21.71% | -0.73 27.72% | -0.53 27.90% | -0.31 41.09% | -0.17 45.72% | 0.52 409.09% | 0.85 62.75% | 1.18 39.76% | 1.53 29.31% | 1.88 22.67% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 43.47% | -0.10 46.73% | -0.10 13.30% | -0.08 68.34% | -0.06 38.54% | -0.07 27.66% |
| Revenue Q2Q % growth | 6.728M -32.87% | 9.782M -0.25% | 8.16M -7.61% | 9.078M 9.93% | 10.098M 50.09% | 11.424M 16.79% |
| EBITDA Q2Q % growth | -6.732M 46.77% | -7.038M 35.21% | -6.834M 32.99% | -6.018M 24.15% | -2.958M 56.06% | -1.122M 84.06% |
| EBIT Q2Q % growth | -9.713M 24.83% | -10.022M 10.82% | -3.468M 66.30% | -408K 94.98% | 100.00% | 2.958M 129.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.24 -71.43% | -0.11 | -0.13 | -108.96% |
| Q1 2023 Q2Q % growth | -0.12 52.00% | -0.12 | 0.00 | 0.80% |
| Q4 2022 Q2Q % growth | -0.18 40.00% | -0.16 | -0.02 | -10.52% |
| Q3 2022 Q2Q % growth | -0.16 42.86% | -0.16 | 0.00 | 1.47% |
| Q2 2022 Q2Q % growth | -0.14 50.00% | -0.21 | 0.07 | 33.85% |
| Q1 2022 Q2Q % growth | -0.25 -66.67% | -0.18 | -0.07 | -42.71% |
| Q4 2021 Q2Q % growth | -0.30 65.91% | -0.27 | -0.03 | -10.29% |
| Q3 2021 Q2Q % growth | -0.28 -100.00% | -0.32 | 0.04 | 12.85% |
| Q2 2021 Q2Q % growth | -0.28 -27.27% | -0.14 | -0.14 | -96.08% |
| Q1 2021 Q2Q % growth | -0.15 -200.00% | -0.24 | 0.09 | 37.42% |
| Q4 2020 Q2Q % growth | -0.88 -72.55% | -0.24 | -0.64 | -264.54% |
| Q3 2020 Q2Q % growth | -0.14 93.49% | -0.20 | 0.06 | 31.37% |
| Q2 2020 Q2Q % growth | -0.22 -1,200.00% | -0.13 | -0.09 | -72.55% |
| Q1 2020 Q2Q % growth | -0.05 44.44% | -0.15 | 0.10 | 65.80% |
| Q4 2019 Q2Q % growth | -0.51 | -0.07 | -0.44 | -681.25% |
| Q3 2019 Q2Q % growth | -2.15 | -0.21 | -1.94 | -940.91% |
| Q2 2019 Q2Q % growth | 0.02 | -0.15 | 0.17 | 113.52% |
| Q1 2019 Q2Q % growth | -0.09 | -0.06 | -0.03 | -60.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 8.258M -2.25% | 10.831M | -2.573M | -23.76% |
| Q1 2023 Q2Q % growth | 8.832M -58.81% | 9.63M | -798K | -8.29% |
| Q4 2022 Q2Q % growth | 9.807M 242.90% | 12.856M | -3.049M | -23.72% |
| Q3 2022 Q2Q % growth | 10.022M 356.38% | 10.421M | -399K | -3.83% |
| Q2 2022 Q2Q % growth | 8.448M -32.12% | 8.689M | -241K | -2.77% |
| Q1 2022 Q2Q % growth | 21.444M 2,193.48% | 7.588M | 13.856M | 182.60% |
| Q4 2021 Q2Q % growth | 2.86M -91.72% | 3.164M | -304K | -9.61% |
| Q3 2021 Q2Q % growth | 2.196M -91.47% | 2.405M | -209K | -8.69% |
| Q2 2021 Q2Q % growth | 12.445M -70.12% | 35.241M | -22.796M | -64.69% |
| Q1 2021 Q2Q % growth | 935K -97.98% | 31.263M | -30.328M | -97.01% |
| Q4 2020 Q2Q % growth | 34.532M -36.40% | 36.448M | -1.916M | -5.26% |
| Q3 2020 Q2Q % growth | 25.751M -51.64% | 37.783M | -12.032M | -31.85% |
| Q2 2020 Q2Q % growth | -29.68% | 41.65M | % | |
| Q1 2020 Q2Q % growth | -26.26% | 46.381M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 4.04% | 2.76% | -30.11% |
| Revenue | 0% | -51.29% | 5.95% | -23.85% |